Zoetis Inc
ZTS127.890USD
+5.020+4.09%
종가 11/25, 16:00（ET）시세는 15분 지연됩니다
56.46B시가총액
21.30P/E TTM
자세한 내용은 Zoetis Inc 회사
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Zoetis Inc 정보
종목 코드 ZTS
회사 이름Zoetis Inc
상장일Feb 01, 2013
CEOMs. Kristin C. Peck
직원 수13800
유형Ordinary Share
회계 연도 종료Feb 01
주소10 Sylvan Way
도시PARSIPPANY
증권 거래소NYSE Consolidated
국가United States of America
우편 번호07054
전화19738227000
웹사이트https://www.zoetis.com/
종목 코드 ZTS
상장일Feb 01, 2013
CEOMs. Kristin C. Peck
Zoetis Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
기타
384.00M
15.61%
지역별USD
이름
수익
비율
United States
1.36B
55.12%
Other emerging markets
225.00M
9.15%
Other Developed
162.00M
6.59%
Brazil
93.00M
3.78%
Australia
83.00M
3.37%
기타
541.00M
21.99%
사업별
지역별
사업별USD
이름
수익
비율
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
기타
384.00M
15.61%
주식 보유 통계
마지막 업데이트: Sat, Nov 15
마지막 업데이트: Sat, Nov 15
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
기타
74.46%
주주
주주
비율
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
기타
74.46%
주주 유형
주주
비율
Investment Advisor
49.05%
Investment Advisor/Hedge Fund
32.09%
Research Firm
4.42%
Insurance Company
3.92%
Bank and Trust
2.62%
Pension Fund
2.55%
Hedge Fund
1.56%
Sovereign Wealth Fund
1.25%
Family Office
0.15%
기타
2.40%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
41.69M
9.41%
+326.69K
+0.79%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
22.66M
5.11%
-498.13K
-2.15%
Jun 30, 2025
State Street Investment Management (US)
19.74M
4.45%
-59.31K
-0.30%
Jun 30, 2025
State Farm Insurance Companies
16.84M
3.8%
-34.10K
-0.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.08M
2.5%
+95.29K
+0.87%
Jun 30, 2025
Wellington Management Company, LLP
8.89M
2.01%
+2.82M
+46.56%
Jun 30, 2025
Polen Capital Management, LLC
8.42M
1.9%
-375.82K
-4.27%
Jun 30, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.75M
1.52%
+4.58M
+209.96%
Jun 30, 2025
Wells Fargo Advisors
5.83M
1.32%
-180.38K
-3.00%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.19M
1.17%
+131.36K
+2.60%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
ProShares Pet Care ETF
9.91%
VanEck Agribusiness ETF
7.63%
VanEck Pharmaceutical ETF
4.34%
iShares U.S. Pharmaceuticals ETF
4.32%
Honeytree US Equity ETF
3.92%
First Trust NASDAQ Pharmaceuticals ETF
3.43%
Polen Capital Global Growth ETF
3.35%
iShares ESG Aware MSCI USA Value ETF
3.19%
SPDR S&P Pharmaceuticals ETF
2.35%
Siren DIVCON Dividend Defender ETF
2.07%
더 보기
ProShares Pet Care ETF
비율9.91%
VanEck Agribusiness ETF
비율7.63%
VanEck Pharmaceutical ETF
비율4.34%
iShares U.S. Pharmaceuticals ETF
비율4.32%
Honeytree US Equity ETF
비율3.92%
First Trust NASDAQ Pharmaceuticals ETF
비율3.43%
Polen Capital Global Growth ETF
비율3.35%
iShares ESG Aware MSCI USA Value ETF
비율3.19%
SPDR S&P Pharmaceuticals ETF
비율2.35%
Siren DIVCON Dividend Defender ETF
비율2.07%
주식 배당금
지난 5년 동안 총
2.94B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Zoetis Inc의 상위 5대 주주는 누구인가요?
Zoetis Inc의 상위 5대 주주는 다음과 같습니다:
The Vanguard Group, Inc.는 41.69M주의 주식을 보유하고 있으며, 전체 주식의 9.41%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 22.66M주의 주식을 보유하고 있으며, 전체 주식의 5.11%를 차지합니다.
State Street Investment Management (US)는 19.74M주의 주식을 보유하고 있으며, 전체 주식의 4.45%를 차지합니다.
State Farm Insurance Companies는 16.84M주의 주식을 보유하고 있으며, 전체 주식의 3.80%를 차지합니다.
Geode Capital Management, L.L.C.는 11.08M주의 주식을 보유하고 있으며, 전체 주식의 2.50%를 차지합니다.
The Vanguard Group, Inc.는 41.69M주의 주식을 보유하고 있으며, 전체 주식의 9.41%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 22.66M주의 주식을 보유하고 있으며, 전체 주식의 5.11%를 차지합니다.
State Street Investment Management (US)는 19.74M주의 주식을 보유하고 있으며, 전체 주식의 4.45%를 차지합니다.
State Farm Insurance Companies는 16.84M주의 주식을 보유하고 있으며, 전체 주식의 3.80%를 차지합니다.
Geode Capital Management, L.L.C.는 11.08M주의 주식을 보유하고 있으며, 전체 주식의 2.50%를 차지합니다.
Zoetis Inc의 상위 3대 주주 유형은 무엇인가요?
Zoetis Inc의 주요 주주 유형 상위 3가지는
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
Zoetis Inc(ZTS)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Zoetis Inc의 주식을 보유한 기관은 총 3275곳이며, 이들이 보유한 주식의 총 가치는 약 435.62M로 전체 발행 주식의 98.29%를 차지합니다. 이는 2025Q2 대비 0.29% 증가한 수치입니다.
Zoetis Inc의 최대 수익원은 무엇인가요?
FY2025Q2 기준, Zoetis Inc의 Parasiticides 부문이 가장 높은 매출을 기록했으며, 금액은 673.00M로 전체 매출의 27.36%를 차지했습니다.
